64
Participants
Start Date
September 30, 2005
Primary Completion Date
December 31, 2007
Study Completion Date
January 31, 2008
Pentoxifylline
"Participants will be randomized to receive either pentoxifylline or placebo in addition to their stable steroid therapy. Active drug and placebo preparations will be supplied as gel capsules of identical size, appearance and taste. Active drug capsules will contain one 400 mg time-release pentoxifylline tablet and inert filler. Placebo capsules will contain inert filler.~Based on weight at screening, \<30 mg will receive 1 400 capsule/day; 30-49 kg will receive two 400 capsules/day; 50 kg or greater will receive three 400 mg capsules/day."
Hospital Frances, Buenos Aires
Children's Hospital, Melbourne
Children's Hospital of Pittsburgh, Pittsburgh
Children's National Medical Center, Washington D.C.
IRCCS C Mondino Foundation, Pavia
University of Tennessee, Memphis
Mayo Clinic, Rochester
Washington University, St. Louis, St Louis
Hadassah Hospital, Mt. Scopus, Jerusalem
Alberta Children's Hospital, Calgary
University of Alberta, Edmonton
Cooperative International Neuromuscular Research Group
NETWORK